Article info

Download PDFPDF

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
Free
  1. Correspondence to:
    Dr L De Rycke
    Department of Rheumatology, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium; leen.deryckeUgent.be
View Full Text

Citation

De Rycke L, Verhelst X, Kruithof E, et al
Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis

Publication history

  • Accepted May 16, 2004
  • First published May 27, 2004.
Online issue publication 
January 12, 2005

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.